Journey Medical Corp.

Dr. Rosenwald has served as a member of the Board of Directors since October 2009 and as Chairman, President and Chief Executive Officer of Fortress Biotech, Inc. since December 2013. Dr. Rosenwald also serves as a Director of Mustang Bio, Inc., Chairman of the Board of Directors of Avenue Therapeutics, Inc., and a Director of Checkpoint Therapeutics, Inc. From November 2014 to August 2015, he served as Interim President and Chief Executive Officer of Checkpoint Therapeutics, Inc. From 1991 to 2008, Dr. Rosenwald served as the Chairman of Paramount BioCapital, Inc. Over the last 25 years, Dr. Rosenwald has acted as a biotechnology entrepreneur and has been involved in the founding and recapitalization of numerous public and private biotechnology and life sciences companies. Dr. Rosenwald received his B.S. in Finance from Pennsylvania State University and his M.D. from Temple University School of Medicine.

Claude has more than 30 years of experience in commercializing some of the most successful dermatology products in the world. He served as Vice President of Dermatology Sales at Medicis Pharmaceutical Corporation and has held various leadership positions in marketing and sales for therapeutic and aesthetic dermatology. He has executed more than 50 product launches during his career. In 2012, Valeant Pharmaceuticals International Inc. acquired Medicis for approximately $2.6B. Claude received his B.S. in Business and Marketing from Rutgers University.

Ernie has more than 40 years of financial and business experience in the pharmaceutical industry, serving as CFO for the last 13 years in both public and privately held healthcare companies. From 2013 to 2019, Ernie served as the CFO, Treasurer and Secretary for BioDelivery Sciences, a public, specialty pharmaceutical company. Ernie began his career with GlaxoSmithKline, where he spent 17 years in financial roles of increasing responsibility including U.S. Pharmaceuticals, where he was Group Controller responsible for sales of $3.5B. Ernie received his BA Degree from Lycoming College, his MBA in Finance at Saint Joseph’s University, and is a licensed CPA.

Robert has more than 24 years of experience in pharmaceutical, lab and medical management, and oversees all sales, trade and managed care functions at Journey. He came to Journey from The Dermatology Alliance, where he served as Managing Partner for one of the nation’s largest independent physician associations in the specialty of dermatology. Robert received his B.S. in Business Administration and Finance from Seton Hall University.

Ramsey has more than 12 years of experience advising pharmaceutical and healthcare companies. Prior to joining Journey, he led a legal and advisory firm in Washington, D.C. focusing on corporate, commercial, regulatory, governance, securities matters and transactions. Before private practice, he was with Medicis where he worked on the commercial team in the aesthetics division. He also served as a legal fellow at the U.S. Securities & Exchange Commission focusing on enforcement and compliance matters. Ramsey received his LL.M. degrees in Taxation and Securities & Financial Regulation from Georgetown University Law Center and his J.D. from the Shepard Broad Law Center.